Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells
Open Access
- 29 August 2023
- journal article
- research article
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 13 (1) , 1-11
Abstract
DNA topoisomerases are essential nuclear enzymes in correcting topological DNA errors and maintaining DNA integrity. Topoisomerase inhibitors are a significant class of cancer chemotherapeutics with a definite curative effect. Natural products are a rich source of lead compounds for drug discovery, including anti-tumor drugs. In this study, we found that narciclasine (NCS), an amaryllidaceae alkaloid, is a novel inhibitor of topoisomerase I (topo I). Our data demonstrated that NCS inhibited topo I activity and reversed its unwinding effect on p-HOT DNA substrate. However, it had no obvious effect on topo II activity. The molecular mechanism of NCS inhibited topo I showed that NCS did not stabilize topo-DNA covalent complexes in cells, indicating that NCS is not a topo I poison. A blind docking result showed that NCS could bind to topo I, suggesting that NCS might be a topo I suppressor. Additionally, NCS exhibited a potent anti-proliferation effect in various cancer cells. NCS arrested the cell cycle at G2/M phase and induced cell apoptosis. Our study reveals the antitumor mechanisms of NCS and provides a good foundation for the development of anti-cancer drugs based on topo I inhibition. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (21907044, 81460559, 82160697)
- Applied Basic Research Foundation of Yunnan Province (202101AT070155, 202201AS070086, 202101AY070001-011, 202201AY070001-003, 202101AY070001-041)
- Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province
- Yunnan Provincial Science and Technology Department (202305AF150054)
- Yunnan Provincial Department of Education (2022J0213)
This publication has 39 references indexed in Scilit:
- Caspase-3 Activation Is a Critical Determinant of Genotoxic Stress-Induced Apoptosis2014
- Narciclasine as well as other Amaryllidaceae Isocarbostyrils are Promising GTP‐ase Targeting Agents against Brain CancersMedicinal Research Reviews, 2012
- A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cellsEuropean Journal of Pharmacology, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Structure−Activity Relationship Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae Isocarbostyril Derivative) as Potential Anticancer AgentsJournal of Medicinal Chemistry, 2009
- The Amaryllidaceae Isocarbostyril Narciclasine Induces Apoptosis By Activation of the Death Receptor and/or Mitochondrial Pathways in Cancer Cells But Not in Normal FibroblastsNeoplasia, 2007
- A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric AdenocarcinomaDigestive Diseases and Sciences, 2005
- Camptothecin: current perspectivesBioorganic & Medicinal Chemistry, 2004
- Location of resistance to the alkaloid narciclasine in the 60S ribosomal subunitFEBS Letters, 1975
- Narciclasine: an antitumour alkaloid which blocks peptide bond formation by eukaryotic ribosomesFEBS Letters, 1975